ClinicalTrials.Veeva

Menu

Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials

A

AIDS Malignancy Consortium

Status

Completed

Conditions

Malignant Neoplasm
Precancerous Condition
HIV Infection

Treatments

Other: questionnaire administration

Study type

Observational

Funder types

Other
NETWORK
Industry
NIH

Identifiers

NCT01946217
U01CA121947 (U.S. NIH Grant/Contract)
NCI-2013-01152 (Registry Identifier)
AMC-S006 (Other Identifier)

Details and patient eligibility

About

This pilot research trial studies factors affecting patient participation in Acquired Immune Deficiency Syndrome (AIDS) Malignancy Clinical Trials Consortium clinical trials. Determining how patients makes decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.

Full description

PRIMARY OBJECTIVES:

I. To identify participant-level factors affecting recruitment of potentially eligible participants in AIDS Malignancy Clinical Trials Consortium (AMC) studies at core and affiliated sites.

SECONDARY OBJECTIVES:

I. To describe the socio-demographic characteristics for participation and non-participation in AMC clinical trials among all approached volunteers across AMC sites.

II. To characterize socio-demographic characteristics with motivation and decision making among those who consented to participate in an AMC trial.

III. To identify the perceived barriers associated with clinical trial participation among those who did not consent to participate in an AMC clinical trial.

IV. To better understand how potential study volunteers learn about AMC clinical trials and by what means are they referred to a particular study.

OUTLINE:

Participants complete the Improving Participation in AMC Clinical Trials (IMPACTS) survey comprising questions about socio-demographic information and clinical trial participation.

Enrollment

82 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HIV-infected participants
  • Cancer or anal dysplasia diagnosis
  • Offered informed consent on an AMC interventional clinical trial
  • Ability to understand and the willingness to sign a written informed consent document

Exclusion criteria

  • Inability to provide informed consent

Trial design

82 participants in 1 patient group

Observational (questionnaire administration)
Description:
Participants complete the IMPACTS survey comprising questions about socio-demographic information and clinical trial participation.
Treatment:
Other: questionnaire administration

Trial contacts and locations

14

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems